Monthly M&A Insider - Mergermarket
Monthly M&A Insider - Mergermarket
Monthly M&A Insider - Mergermarket
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Introduction<br />
Despite a reasonably subdued first quarter of M&A, there have still been some deals which have<br />
defied the trend, such as the Pfizer/Wyeth deal, worth a cool $64bn.<br />
In North America in Q1 there were 539 deals worth a total<br />
of $226.3bn. The highest deal for the month of March in<br />
the region was Merck & Co’s acquisition of Schering Plough<br />
Corporation for $43.1bn, which has taken on a similar form of<br />
the reverse termination fee that was used in the Pfizer deal,<br />
demonstrating the watertight measures needed to complete<br />
a deal in the current climate.<br />
In Europe, the first quarter of 2009 saw a total of €82.7bn<br />
from 675 deals. Of the top 15 deals, three were government<br />
bailouts. These included the much publicised bailout of Lloyd<br />
banking group and the Royal Bank of Scotland. Additionally,<br />
the Government of the Flemish region in Belgium acquired<br />
KBC Group, for €2bn. The Energy, Mining & Utilities sector<br />
featured heavily on the top deals table, with eight of the top<br />
15 deals originating in the sector. Endesa’s takeover by Enel<br />
came in with the highest value at €11.1bn.<br />
Head of Research – Elias Latsis<br />
Editor – Anna Henderson<br />
Europe: Sola Akinola<br />
Asia-Pacific: Debbie Jung, Chunshek Chan<br />
Greater China: Maggie Cheung, Debbie Jung/Maggie Cheung<br />
Japan: Shunsuke Okano<br />
Australia: Cicilie Lofsgard<br />
North America: Yasmin Salfati, Irina Arefyeva<br />
Russia: Aksana Fitzpatrick<br />
France: Damien Julliard, Sylvia Traganida<br />
CEE/CIS: Nulifer Sezer, Magdalena Urbanska<br />
Moving onto April there are certainly some positive<br />
developments in M&A, and although this is not yet reason to<br />
celebrate, it is encouraging that the frequency and value of<br />
deals may be starting to pick up slightly. Sun Microsystems<br />
is to be bought by US software services company, Oracle for<br />
$6.7bn, whilst in the pharmaceutical sphere GlaxoSmithKline<br />
has agreed to acquire Stiefel for $2.9bn. Whether this activity<br />
continues is tentative, and a representative from Nomura<br />
recently supported this view when he told the Financial<br />
Times that, “confidence is still fragile and much will depend<br />
on how markets behave over the coming months.”<br />
mergermarket are pleased to offer you the April edition of<br />
<strong>Monthly</strong> M&A <strong>Insider</strong>, a publication which provides you with<br />
features by mergermarket journalists, and all monthly deals,<br />
potential activity and deal drivers. We hope you continue to<br />
find it useful.<br />
By Anna Henderson, Remark<br />
Benelux: Kathleen Van Aerden<br />
UK: Virginia Christopanou, Petra Witowski<br />
Nordic: Laya Montelibano<br />
Germany: Sola Akinola<br />
Italy: Giovanni Gallorini, Zaynab Dost<br />
Iberia: Samuel Tedjasukmana, Virginia Garcia Martinez<br />
LatAm: Jennifer Ruiz<br />
For advertising opportunities contact:<br />
Simon Anam<br />
Tel: +44 (0)20 7059 6124<br />
sa@mergermarket.com<br />
<strong>Monthly</strong> M&A Report – 3